- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
SingleCell Biotech Unveils Single-Cell Assay Linking Tumor Cell Behavior to Molecular Profiles
Company's data presented at AACR Annual Meeting aims to inform drug development through high-throughput analysis.
Apr. 17, 2026 at 11:26pm
Got story updates? Submit your updates here. ›
SingleCell Biotechnology's novel single-cell assay aims to unlock the complex molecular and behavioral profiles of individual tumor cells, providing crucial insights to advance cancer drug development.Dallas TodaySingleCell Biotechnology, a biotech company developing technologies to measure tumor cell behavior at single-cell resolution, announced the presentation of new data at the American Association for Cancer Research (AACR) Annual Meeting. The data demonstrate a scalable approach to better understand tumor cell behavior and inform drug development.
Why it matters
Understanding the complex behavior and molecular profiles of individual tumor cells is crucial for developing more effective cancer treatments. SingleCell's high-throughput single-cell assay provides a powerful tool to uncover insights that could accelerate drug discovery and personalized medicine.
The details
SingleCell Biotechnology's novel assay enables the linking of clonal growth phenotypes to molecular profiles at single-cell resolution. This approach allows researchers to better understand the heterogeneity of tumor cells and how they respond to different treatments.
- The data were presented at the AACR Annual Meeting on April 17, 2026.
The players
SingleCell Biotechnology
A biotechnology company developing technologies to measure tumor cell behavior at single-cell resolution.
The takeaway
SingleCell's innovative single-cell assay provides a powerful tool for researchers and drug developers to gain deeper insights into tumor cell behavior, which could lead to the development of more effective and personalized cancer treatments.
Dallas top stories
Dallas events
Apr. 18, 2026
Dansyn




